FDA Approved: PREGABALIN — Supplemental Application (Tris Pharma Inc)

View source ↗

Summary

FDA approves Tris Pharma Inc's supplemental application for pregabalin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Epilepsy
• Fibromyalgia
• Generalized Anxiety Disorder
• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)